|
Date of decision
|
20 September 2005
|
|
|
Case number
|
W 0043/04
- 3.3.02
|
|
|
Application number
|
PCT EP2003/009166
|
|
|
|
|
|
|
Title of the application
|
Compositions and methods for treating cancer using cytotoxic CD44
antibody immunoconjugates and chemotherapeutic agents
|
|
|
Applicant name
|
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
|
|
|
|
|
|
Keywords
An oral disclosure under Rule 64.2 PCT is not prior art relevant
for the consideration of inventive step and cannot be used in the
reasoning accompanying the invitation to pay additional fees.
|
|
|
|
|
